This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Archer Daniels' Solid Growth Efforts Help Revive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) weak Carbohydrate Solutions segment is concerning. However, the company's growth efforts including the Readiness program is likely to aid performance.
General Mills (GIS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MGP (MGPI) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
MGP (MGPI) delivered earnings and revenue surprises of -11.54% and -2.48%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
MGP (MGPI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MGP (MGPI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MGP (MGPI) Q1 Earnings Beat Estimates
by Zacks Equity Research
MGP (MGPI) delivered earnings and revenue surprises of 14.00% and -2.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Archer Daniels (ADM) Q1 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports dismal first-quarter 2019 earnings due to adverse winter weather conditions in North America, which hurt the company's operations.
Earnings Preview: MGP (MGPI) Q1 Earnings Expected to Decline
by Zacks Equity Research
MGP (MGPI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
Low Inflation Data Reduces Rate Hike Possibility: 5 Picks
by Nalak Das
Tamed inflation together with a robust labor market has compelled the Fed to continue with its dovish monetary stance.
Molson Coors Launches Two Beer Brands Online in Singapore
by Zacks Equity Research
Molson Coors' (TAP) Carling and Blue Moon brands are now available off-premise in Singapore through Amazon Prime Now.
Global Economic Growth Concerns Resurface: 5 Safe Picks
by Nalak Das
Concerns over slowing global growth have contributed to this uncertainty and dented investors' confidence to some extent.
Clorox (CLX) Thriving on 2020 Strategy & Digital Efforts
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on 2020 Strategy, focus on e-commerce and brand-management initiatives. It also has a robust earnings surprise history.
3 Reasons Why MGP (MGPI) Is a Great Growth Stock
by Zacks Equity Research
MGP (MGPI) could produce exceptional returns because of its solid growth attributes.
Can Colgate's (CL) Cost-Savings Programs Offset Margin Woes?
by Zacks Equity Research
Colgate (CL) struggles with strained margins for quite a while now. Nevertheless, the company's cost-savings program appears encouraging.
General Mills (GIS) Beats on Q3 Earnings & Sales, Updates View
by Zacks Equity Research
General Mills (GIS), which is currently focused on Consumer First strategy and cost-reduction initiatives, posts impressive third-quarter fiscal 2019 results.
Invest Carefully Despite a Dovish Fed: 5 Safe Picks
by Nalak Das
The Fed has also reduced the growth projection of U.S. GDP, while raising its previous projection for unemployment.
General Mills (GIS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Why MGP (MGPI) Is a Great Growth Stock
by Zacks Equity Research
MGP (MGPI) possesses solid growth attributes, which could help it handily outperform the market.
MGP (MGPI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MGP (MGPI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MGP (MGPI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
MGP (MGPI) delivered earnings and revenue surprises of 1.96% and 2.07%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
MGP (MGPI) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
MGP (MGPI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NOMD vs. MGPI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NOMD vs. MGPI: Which Stock Is the Better Value Option?
Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for DWAS
CHEF vs. MGPI: Which Stock Is the Better Value Option?
by Zacks Equity Research
CHEF vs. MGPI: Which Stock Is the Better Value Option?
Should PowerShares DWA SmallCap Momentum Portfolio (DWAS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DWAS